Letter to Editor
BibTex RIS Cite

Risk factors for invasive mechanical ventilation after thoracentesis

Year 2025, Volume: 16 Issue: 1, 238 - 239, 25.03.2025
https://doi.org/10.18663/tjcl.1655240

Abstract

Identifying risk factors for invasive mechanical ventilation (IMV) following thoracentesis in critically ill patients is crucial for optimizing management strategies. Recent findings indicate that vasopressor use and prolonged intensive care unit (ICU) stay are independent predictors of IMV requirement, suggesting a heightened vulnerability in hemodynamically unstable patients. Additionally, variations in comorbidity profiles may influence IMV risk, underscoring the potential utility of standardized assessment tools such as the Charlson Comorbidity Index. A comprehensive risk stratification approach incorporating both acute physiological status and chronic disease burden is essential for improving clinical outcomes in ICU patients undergoing thoracentesis.

References

  • Doğancı M, Eraslan Doğanay G, Çakıroğlu EB, et al. Üçüncü basamak yoğun bakımda torasentez uygulanan hastalarda invaziv mekanik ventilasyon ihtiyacı için risk faktörlerinin değerlendirilmesi. Turk J Clin Lab 2024; 2: 147-155
  • Walden AP, Jones QC, Matsa R, et al. Pleural effusions on the intensive care unit; hidden morbidity with therapeutic potential. Respirology. 2013;18(2):246-54.
  • Bateman M, Alkhatib A, John T, et al. Pleural Effusion Outcomes in Intensive Care: Analysis of a Large Clinical Database. J Intensive Care Med. 2020 Jan;35(1):48-54.
  • Bateman M, Alkhatib A, John T, Parikh M, Kheir F. Pleural Effusion Outcomes in Intensive Care: Analysis of a Large Clinical Database. J Intensive Care Med. 2020;35(1):48-54.
  • Park S, Kim WY, Baek MS. Risk Factors for Mortality Among Mechanically Ventilated Patients Requiring Pleural Drainage. Int J Gen Med. 2022;15:1637-1646.
  • Song SE, Lee SH, Jo EJ, et al. The Prognostic Value of the Charlson's Comorbidity Index in Patients with Prolonged Acute Mechanical Ventilation: A Single Center Experience. Tuberc Respir Dis (Seoul). 2016;79(4):289-294.

Torasentez sonrası invaziv mekanik ventilasyon için risk faktörleri

Year 2025, Volume: 16 Issue: 1, 238 - 239, 25.03.2025
https://doi.org/10.18663/tjcl.1655240

Abstract

Kritik hastalarda torasentez sonrası invaziv mekanik ventilasyon (IMV) için risk faktörlerini belirlemek, yönetim stratejilerini optimize etmek için çok önemlidir. Son bulgular, vazopressör kullanımı ve uzun süreli yoğun bakım ünitesinde (YBÜ) kalmanın IMV gereksiniminin bağımsız öngörücüleri olduğunu ve hemodinamik olarak dengesiz hastalarda daha yüksek bir hassasiyet olduğunu göstermektedir. Ek olarak, eşlik eden hastalık profillerindeki değişiklikler IMV riskini etkileyebilir ve Charlson Eşlik Eden Hastalık İndeksi gibi standart değerlendirme araçlarının potansiyel faydasını vurgular. Hem akut fizyolojik durumu hem de kronik hastalık yükünü içeren kapsamlı bir risk sınıflandırması yaklaşımı, torasentez geçiren YBÜ hastalarında klinik sonuçları iyileştirmek için önemlidir.

References

  • Doğancı M, Eraslan Doğanay G, Çakıroğlu EB, et al. Üçüncü basamak yoğun bakımda torasentez uygulanan hastalarda invaziv mekanik ventilasyon ihtiyacı için risk faktörlerinin değerlendirilmesi. Turk J Clin Lab 2024; 2: 147-155
  • Walden AP, Jones QC, Matsa R, et al. Pleural effusions on the intensive care unit; hidden morbidity with therapeutic potential. Respirology. 2013;18(2):246-54.
  • Bateman M, Alkhatib A, John T, et al. Pleural Effusion Outcomes in Intensive Care: Analysis of a Large Clinical Database. J Intensive Care Med. 2020 Jan;35(1):48-54.
  • Bateman M, Alkhatib A, John T, Parikh M, Kheir F. Pleural Effusion Outcomes in Intensive Care: Analysis of a Large Clinical Database. J Intensive Care Med. 2020;35(1):48-54.
  • Park S, Kim WY, Baek MS. Risk Factors for Mortality Among Mechanically Ventilated Patients Requiring Pleural Drainage. Int J Gen Med. 2022;15:1637-1646.
  • Song SE, Lee SH, Jo EJ, et al. The Prognostic Value of the Charlson's Comorbidity Index in Patients with Prolonged Acute Mechanical Ventilation: A Single Center Experience. Tuberc Respir Dis (Seoul). 2016;79(4):289-294.
There are 6 citations in total.

Details

Primary Language English
Subjects Intensive Care
Journal Section Letter to Editor
Authors

Korhan Kollu 0000-0002-0973-724X

Publication Date March 25, 2025
Submission Date March 10, 2025
Acceptance Date March 21, 2025
Published in Issue Year 2025 Volume: 16 Issue: 1

Cite

APA Kollu, K. (2025). Risk factors for invasive mechanical ventilation after thoracentesis. Turkish Journal of Clinics and Laboratory, 16(1), 238-239. https://doi.org/10.18663/tjcl.1655240
AMA Kollu K. Risk factors for invasive mechanical ventilation after thoracentesis. TJCL. March 2025;16(1):238-239. doi:10.18663/tjcl.1655240
Chicago Kollu, Korhan. “Risk Factors for Invasive Mechanical Ventilation After Thoracentesis”. Turkish Journal of Clinics and Laboratory 16, no. 1 (March 2025): 238-39. https://doi.org/10.18663/tjcl.1655240.
EndNote Kollu K (March 1, 2025) Risk factors for invasive mechanical ventilation after thoracentesis. Turkish Journal of Clinics and Laboratory 16 1 238–239.
IEEE K. Kollu, “Risk factors for invasive mechanical ventilation after thoracentesis”, TJCL, vol. 16, no. 1, pp. 238–239, 2025, doi: 10.18663/tjcl.1655240.
ISNAD Kollu, Korhan. “Risk Factors for Invasive Mechanical Ventilation After Thoracentesis”. Turkish Journal of Clinics and Laboratory 16/1 (March 2025), 238-239. https://doi.org/10.18663/tjcl.1655240.
JAMA Kollu K. Risk factors for invasive mechanical ventilation after thoracentesis. TJCL. 2025;16:238–239.
MLA Kollu, Korhan. “Risk Factors for Invasive Mechanical Ventilation After Thoracentesis”. Turkish Journal of Clinics and Laboratory, vol. 16, no. 1, 2025, pp. 238-9, doi:10.18663/tjcl.1655240.
Vancouver Kollu K. Risk factors for invasive mechanical ventilation after thoracentesis. TJCL. 2025;16(1):238-9.


e-ISSN: 2149-8296

The content of this site is intended for health care professionals. All the published articles are distributed under the terms of

Creative Commons Attribution Licence,

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.